Digitalk – introducing the pharma digital landscape

At the first Digitalk session, RAPP's team of expert speakers gave an insight into the digital landscape. This first session touched on some of the issues preventing pharma from diving in to digital, as well as looking at the importance of some key tactics such as search engine optimisation (SEO) and external link building. 

The five videos below provide an insight into what you missed!

The morning's session was rounded off with a question and answer section. Here are a taste of some of the questions asked, and answers provided:

Q. Is there a need for pharma to re-assess its focus on who it defines as its customers - ie, not just doctors, HCPs etc but also consumers?

A. Consumers are an important influencing tools (eg, they will go to a GP armed with info found independently) but a challenge from a regulatory point of view. However, there are a lot of innovative ways in which pharma can reach patient groups through social media – the Dose of Digital blog contains an extensive a list.  

Q. Would you trust information provided by a pharma company more than a charity/patient group? And, if there is a charity group providing info to patients, why spend money doing it ourselves?

A. Consumers see pharma companies as experts in a particular disease area and therefore view information they provide as more robust than that from patient advocacy groups. Pharma should also work to provide better quality rich media content to patient sites.

Where you there? What did you think?

"Great event, good balanced information. Looking forward to the next one!"

Gary Monk, brand manager at Janssen-Cilag

Send your comments for inclusion here to webeditor@pmlive.com 

About Digitalk
Digitalk is an initiative designed to explore how leading edge digital marketing techniques can be used in the pharma market. Digitalk is produced by RAPP

You can become part of the conversation by joining the Digitalk group on LinkedIn or by registering for the next breakfast meeting